Sign in

CIK 0001157075

  • Non-accelerated filer
  • Smaller reporting company

PharmaCyte Biotech, Inc.

Sign in to watch
Ticker
PMCB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Apr 30
Incorporated
NV
Entity type
Operating
EIN
621772151
Phone
+1 917-595-2850
Business address
3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS, NV, 89169
Former names
NUVILEX, INC., EFOODSAFETY COM INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-07 Silverman Joshua CEO and President Purchase +40,000 $0.83 $33K 416,250
2026-01-06 Silverman Joshua CEO and President Purchase +30,000 $0.79 $24K 376,250
2026-01-05 Silverman Joshua CEO and President Purchase +30,000 $0.78 $23K 346,250
2025-12-12 Silverman Joshua CEO and President Grant or award +575,000 575,000
2025-12-12 Silverman Joshua CEO and President Shares withheld for taxes −258,750 $1.02 $264K 316,250
2023-11-20 Silverman Joshua Interim CEO, Interim President Grant or award · Stock Option (Right to Buy) +170,000 170,000

Page 1 of 1 · 6 trades